The antineoplastic effect of carnosine is accompanied by induction of PDK4 and can be mimicked by l-histidine

Amino Acids

Volumn 46, Issue 4, 2014, Pages 1009-1019

  Letzien, Ulrike ^a   Oppermann, Henry ^a   Meixensberger, Jürgen ^a   Gaunitz, Frank ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Cancer; Carnosine; Glioblastoma; l Histidine; PDK4

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; CARNOSINE; HISTIDINE; PROTEIN KINASE; PYRUVATE DEHYDROGENASE KINASE 4; PYRUVIC ACID;

GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ALANINE; ANTINEOPLASTIC AGENTS; CARNOSINE; CELL LINE, TUMOR; HISTIDINE; HUMANS; PROTEIN KINASES; PYRUVIC ACID; UP-REGULATION;

EID: 84898906868     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1664-8     Document Type: Article

References (30)

1. Boldyrev AA, Aldini G, Derave W (2013) Physiology and pathophysiology of carnosine. Physiol Rev 93:1803-1845
2. Bunik VI, Tylicki A, Lukashev NV (2013) Thiamin diphosphate-dependent enzymes: from enzymology to metabolic regulation, drug design and disease models. FEBS J. doi: 10.1111/febs.12512
3. Cartwright SP, Bill RM, Hipkiss AR (2012) L-carnosine affects the growth of Saccharomyces cerevisiae in a metabolism-dependent manner. PLoS ONE 7:e45006
4. Daniel H, Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflug Arch Eur J Phys 447:610-618
5. Gaunitz F, Heise K (2003) HTS compatible assay for antioxidative agents using primary cultured hepatocytes. Assay Drug Dev Technol 1:469-477
6. Gaunitz F, Hipkiss AR (2012) Carnosine and cancer: a perspective. Amino Acids 43:135-142
7. Gautam P, Nair SC, Gupta MK, Sharma R, Polisetty RV, Uppin MS, Sundaram C, Puligopu AK, Ankathi P, Purohit AK, Chandak GR, Harsha HC, Sirdeshmukh R (2012) Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis. PLoS ONE 7:e46153
8. Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, Brugge JS (2011) Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev 25:1716-1733
9. Gulewitsch W, Amiradzibi S (1900) Ueber das Carnosin, eine neue organische Base des Fleischextraktes. Ber Deut Chem Ges 33:1902-1903
10. Hipkiss AR, Gaunitz F (2013) Inhibition of tumour cell growth by carnosine: some possible mechanisms. Amino Acids. doi: 10.1007/s00726-013-1627-5
11. Holliday R, McFarland GA (1996) Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine. Br J Cancer 73:966-971
12. Horii Y, Shen J, Fujisaki Y, Yoshida K, Nagai K (2012) Effects of l-carnosine on splenic sympathetic nerve activity and tumor proliferation. Neurosci Lett 510:1-5
13. Icard P, Poulain L, Lincet H (2012) Understanding the central role of citrate in the metabolism of cancer cells. Biochim Biophys Acta 1825:111-116
14. Iovine B, Iannella ML, Nocella F, Pricolo MR, Baldi MR, Bevilacqua MA (2011) Carnosine inhibits KRas-mediated HCT-116 proliferation by affecting ATP and ROS production. Cancer Lett 315:122-128
15. Lenney JF, Peppers SC, Kucera-Orallo CM, George RP (1985) Characterization of human tissue carnosinase. Biochem J 228:653-660
16. Nagai K, Suda T (1986) Antineoplastic effects of carnosine and beta-alanine-physiological considerations of its antineoplastic effects. J Phys Soc Jpn 48:741-747
17. Pilegaard H, Neufer PD (2004) Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc 63:221-226
18. Renner C, Seyffarth A, de Arriba S, Meixensberger J, Gebhardt R, Gaunitz F (2008) Carnosine inhibits growth of cells isolated from human glioblastoma multiforme. Int J Pept Protein Res 14:127-135
19. Renner C, Asperger A, Seyffarth A, Meixensberger J, Gebhardt R, Gaunitz F (2010a) Carnosine inhibits ATP production in cells from malignant glioma. Neurol Res 32:101-105
20. Renner C, Zemitzsch N, Fuchs B, Geiger KD, Hermes M, Hengstler J, Gebhardt R, Meixensberger J, Gaunitz F (2010b) Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model. Mol Cancer 9:2
21. Roche TE, Hiromasa Y (2007) Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci 64:830-849
22. Sakata K, Yamashita T, Maeda M, Moriyama Y, Shimada S, Tohyama M (2001) Cloning of a lymphatic peptide/histidine transporter. Biochem J 356:53-60
23. Smith DE, Clémençon B, Hediger MA (2013) Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med 34:323-336
24. Son DO, Satsu H, Shimizu M (2005) Histidine inhibits oxidative stress- and TNF-alpha-induced interleukin-8 secretion in intestinal epithelial cells. FEBS Lett 579:4671-4677
25. Son DO, Satsu H, Kiso Y, Totsuka M, Shimizu M (2008) Inhibitory effect of carnosine on interleukin-8 production in intestinal epithelial cells through translational regulation. Cytokine 42:265-276
26. Sutendra G, Michelakis ED (2013) Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front Oncol 3:38
27. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D, Ganzhorn AJ, Guenet C, Heintzelmann B, Laucher V, Sauvage C, Smirnova T (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278:6521-6531
28. Vistoli G, Pedretti A, Cattaneo M, Aldini G, Testa B (2006) Homology modeling of human serum carnosinase, a potential medicinal target, and MD simulations of its allosteric activation by citrate. J Med Chem 49:3269-3277
29. Wu G (2013) Functional amino acids in nutrition and health. Amino Acids 45:407-411
30. Yamashita T, Shimada S, Guo W, Sato K, Kohmura E, Hayakawa T, Takagi T, Tohyama M (1997) Cloning and functional expression of a brain peptide/histidine transporter. J Biol Chem 272:10205-10211